Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

The LACNETS Podcast - Top 10 FAQs with neuroendocrine tumor (NET) experts

Innehåll tillhandahållet av Learn Advocate Connect Neuroendocrine Tumor Society. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Learn Advocate Connect Neuroendocrine Tumor Society eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

1y ago 45:51

MP3•Episod hem

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

For more information, visit LACNETS.org/podcast/24.

For more information, visit LACNETS.org.

40 episoder

#Podcasting Education #LACNETS #Neuroendocrine #NET #Carcinoid #Neuroendocrine Tumor #Carcinoid Syndrome #Neoplasm #Pnet #Prrt #Rare Cancers #Functioning Tumor #Non-functioning Tumor #Liver Metastatis